Mitochondrial Stress Signatures and Early Cellular Dysfunction in Metabolic Disease Progression
DOI:
https://doi.org/10.38035/dhps.v4i2.3869Keywords:
Mitochondria, Oxidative Stress, Cellular Dysfunction, Metabolic Diseases, Systematic Literature ReviewAbstract
Mitochondrial dysfunction is an important mechanism in the development of metabolic diseases through increased oxidative stress and impaired cellular function. This study aims to analyze mitochondrial stress signatures and their relationship with early cellular dysfunction in metabolic disease progression. The method used is a Systematic Literature Review (SLR) based on the PRISMA 2020 guidelines by searching scientific articles from PubMed, Scopus, and Web of Science databases. A total of 32 selected studies were analyzed using a narrative synthesis approach to identify biomarker patterns and associated molecular mechanisms. The results showed that increased reactive oxygen species, mtDNA damage, oxidative phosphorylation disorders, and mitophagic changes played an early sign of cellular disorders. The conclusion of the study shows that mitochondrial stress signatures have the potential to be an early indicator of metabolic disease progression as well as a strategic target in the development of biomolecular-based therapeutic diagnoses and interventions.
References
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022). Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nature Reviews Endocrinology, 18(4), 243–258.
Apostolova, N., Vezza, T., Muntane, J., Rocha, M., & Víctor, V. M. (2023). Mitochondrial dysfunction and mitophagy in type 2 diabetes: pathophysiology and therapeutic targets. Antioxidants & Redox Signaling, 39(4–6), 278–320.
Belosludtsev, K. N., Belosludtseva, N. V, & Dubinin, M. V. (2020). Diabetes mellitus, mitochondrial dysfunction and Ca2+-dependent permeability transition pore. International Journal of Molecular Sciences, 21(18), 6559.
Chen, J., Liu, B., Yao, X., Yang, X., Sun, J., Yi, J., Xue, F., Zhang, J., Shen, Y., & Chen, B. (2025). AMPK/SIRT1/PGC‐1α signaling pathway: Molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy. CNS Neuroscience & Therapeutics, 31(11), e70657.
Chen, Y., Liu, X., Liu, Y., Li, Y., Li, D., Mei, Z., & Deng, Y. (2025). Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death & Disease, 16(1), 652.
Choi, W., Woo, G. H., Kwon, T.-H., & Jeon, J.-H. (2025). Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. International Journal of Molecular Sciences, 26(19), 9715.
Cojocaru, K.-A., Luchian, I., Goriuc, A., Antoci, L.-M., Ciobanu, C.-G., Popescu, R., Vlad, C.-E., Blaj, M., & Foia, L. G. (2023). Mitochondrial dysfunction, oxidative stress, and therapeutic strategies in diabetes, obesity, and cardiovascular disease. Antioxidants, 12(3), 658.
Čolak, E., & Pap, D. (2021). The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. Journal of Medical Biochemistry, 40(1), 1.
García-Peña, L. M., Abel, E. D., & Pereira, R. O. (2024). Mitochondrial dynamics, diabetes, and cardiovascular disease. Diabetes, 73(2), 151–161.
Gunawan, A. L., Liparulo, I., & Stahl, A. (2025). Mammalian mitohormesis: from mitochondrial stressors to organismal benefits. The EMBO Journal, 44(20), 5640–5661.
Januszewski, A. S., Blake, R., Zhang, M., Ma, B., Anand, S., Pinkert, C. A., Kelly, D. J., Jenkins, A. J., & Trounce, I. A. (2024). Increased diabetes complications in a mouse model of oxidative stress due to ‘mismatched’mitochondrial DNA. Antioxidants, 13(2), 187.
Jun, L., Tao, Y.-X., Geetha, T., & Babu, J. R. (2024). Mitochondrial adaptation in skeletal muscle: impact of obesity, caloric restriction, and dietary compounds. Current Nutrition Reports, 13(3), 500–515.
Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-Ośko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., & Kaczyńska, K. (2021). Mitochondrial oxidative stress—a causative factor and therapeutic target in many diseases. International Journal of Molecular Sciences, 22(24), 13384.
Li, X., Jiang, O., Chen, M., & Wang, S. (2024). Mitochondrial homeostasis: shaping health and disease. Current Medicine, 3(1), 5.
Li, X., & Yuen, K. F. (2024). A human-centred review on maritime autonomous surfaces ships: impacts, responses, and future directions. Transport Reviews, 44(4), 791–810.
Liu, B.-H., Xu, C.-Z., Liu, Y., Lu, Z.-L., Fu, T.-L., Li, G.-R., Deng, Y., Luo, G.-Q., Ding, S., & Li, N. (2024). Mitochondrial quality control in human health and disease. Military Medical Research, 11(1), 32.
Mani, S., Sevanan, M., Krishnamoorthy, A., & Sekar, S. (2021). A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurological Sciences, 42(11), 4459–4469.
Manojlovic, M., Zafirovic, S., Naglic, D. T., Stokic, E., Rizzo, M., Suri, J. S., & Isenovic, E. R. (2025). Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus—A triangular relationship: A review. Biomolecules and Biomedicine, 26(4), 547.
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D’Alessandro, A. G. (2023). Metabolic syndrome: a narrative review from the oxidative stress to the management of related diseases. Antioxidants, 12(12), 2091.
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023). Mechanisms of oxidative stress in metabolic syndrome. International Journal of Molecular Sciences, 24(9), 7898.
Min, S. H., Kang, G. M., Park, J. W., & Kim, M.-S. (2024). Beneficial effects of low-grade mitochondrial stress on metabolic diseases and aging. Yonsei Medical Journal, 65(2), 55.
Narendra, D. P., & Youle, R. J. (2024). The role of PINK1–Parkin in mitochondrial quality control. Nature Cell Biology, 26(10), 1639–1651.
Nuñez-Selles, A. J., Nuñez-Musa, R. A., & Guillen-Marmolejos, R. A. (2025). Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus. Frontiers in Molecular Biosciences, 12, 1611842.
Olivares-Vicente, M., & Herranz-López, M. (2025). The interplay between oxidative stress and lipid composition in obesity-induced inflammation: antioxidants as therapeutic agents in metabolic diseases. International Journal of Molecular Sciences, 26(17), 8544.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., Stewart, L. A., Thomas, J., Tricco, A. C., Welch, V. A., Whiting, P., & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.
Paredes-Fuentes, A. J., Oliva, C., Urreizti, R., Yubero, D., & Artuch, R. (2023). Laboratory testing for mitochondrial diseases: biomarkers for diagnosis and follow-up. Critical Reviews in Clinical Laboratory Sciences, 60(4), 270–289.
Prasun, P. (2020). Mitochondrial dysfunction in metabolic syndrome. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1866(10), 165838.
Ran, Q., Gao, C., Xiang, C., He, X., Zhang, Y., Zhang, Y., & Chen, H. (2025). Mitochondrial fission process 1 protein: a comprehensive review of its core roles in mitochondrial dynamics, disease, and therapeutic targets. Frontiers in Cell and Developmental Biology, 13, 1646072.
Ryoo, H. D. (2024). The integrated stress response in metabolic adaptation. Journal of Biological Chemistry, 300(4).
Sangwung, P., Petersen, K. F., Shulman, G. I., & Knowles, J. W. (2020). Mitochondrial dysfunction, insulin resistance, and potential genetic implications: potential role of alterations in mitochondrial function in the pathogenesis of insulin resistance and type 2 diabetes. Endocrinology, 161(4), bqaa017.
Shan, Z., Fa, W. H., Tian, C. R., Yuan, C. S., & Jie, N. (2022). Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment. Aging (Albany NY), 14(6), 2902.
Shepard, C. R. (2021). TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Frontiers in Endocrinology, 11, 613639.
Tang, S., Hao, D., Ma, W., Liu, L., Gao, J., Yao, P., Yu, H., Gan, L., & Cao, Y. (2024). Dysfunctional mitochondria clearance in situ: mitophagy in obesity and diabetes-associated cardiometabolic diseases. Diabetes & Metabolism Journal, 48(4), 503–517.
Todosenko, N., Khaziakhmatova, O., Malashchenko, V., Yurova, K., Bograya, M., Beletskaya, M., Vulf, M., Gazatova, N., & Litvinova, L. (2023). Mitochondrial dysfunction associated with mtDNA in metabolic syndrome and obesity. International Journal of Molecular Sciences, 24(15), 12012.
Varra, F.-N., Varras, M., Varra, V.-K., & Theodosis-Nobelos, P. (2024). Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation mediating treatment options. Molecular Medicine Reports, 29(6), 95.
Veluthakal, R., Esparza, D., Hoolachan, J. M., Balakrishnan, R., Ahn, M., Oh, E., Jayasena, C. S., & Thurmond, D. C. (2024). Mitochondrial dysfunction, oxidative stress, and inter-organ miscommunications in T2D progression. International Journal of Molecular Sciences, 25(3), 1504.
Wang, W., & Liu, L. (2025). Advances in the application of human-machine collaboration in healthcare: insights from China. In Frontiers in Public Health (Vol. 13). Frontiers Media SA. https://doi.org/10.3389/fpubh.2025.1507142
Wang, Y., Wang, J., Tao, S., Liang, Z., Xie, R., Liu, N., Deng, R., Zhang, Y., Deng, D., & Jiang, G. (2024). Mitochondrial damage‐associated molecular patterns: A new insight into metabolic inflammation in type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 40(2), e3733.
Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020). Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxidative Medicine and Cellular Longevity, 2020(1), 8609213.
Yu, T., Wang, L., Zhang, L., & Deuster, P. A. (2023). Mitochondrial fission as a therapeutic target for metabolic diseases: insights into antioxidant strategies. Antioxidants, 12(6), 1163.
Zhang, B., Chang, J. Y., Lee, M. H., Ju, S.-H., Yi, H.-S., & Shong, M. (2024). Mitochondrial stress and mitokines: therapeutic perspectives for the treatment of metabolic diseases. Diabetes & Metabolism Journal, 48(1), 1–18.
Zhao, Y., Zhou, Y., Wang, D., Huang, Z., Xiao, X., Zheng, Q., Li, S., Long, D., & Feng, L. (2023). Mitochondrial dysfunction in metabolic dysfunction fatty liver disease (MAFLD). International Journal of Molecular Sciences, 24(24), 17514.
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024). Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 124.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Suherman Jaksa, Abul A'la Al Maududi, Triana Srisantyorini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright :
Authors who publish their manuscripts in this journal agree to the following conditions:
- Copyright in each article belongs to the author.
- The author acknowledges that the DHPS has the right to be the first to publish under a Creative Commons Attribution 4.0 International license (Attribution 4.0 International CC BY 4.0).
- Authors can submit articles separately, arrange the non-exclusive distribution of manuscripts that have been published in this journal to other versions (for example, sent to the author's institutional repository, publication in a book, etc.), by acknowledging that the manuscript has been published for the first time at DHPS.
